查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1924659

內視鏡黏膜下剝離刀市場按產品類型、模式、材質、最終用戶和應用分類－2026-2032年全球預測

Endoscopic Submucosal Dissection Knives Market by Product Type, Mode, Material, End User, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年內視鏡黏膜下剝離刀市場價值為 1.5281 億美元，預計到 2026 年將成長至 1.7586 億美元，預計到 2032 年將達到 3.6747 億美元，複合年成長率為 13.35%。

關鍵市場統計數據
基準年 2025 1.5281億美元
預計年份：2026年 1.7586億美元
預測年份 2032 3.6747億美元
複合年成長率 (%) 13.35%

本文簡要介紹了刀具設計、手術操作要求、臨床醫生需求以及監管預期如何影響先進內視鏡解剖工具的應用。

內視鏡黏膜下剝離刀是現代胃腸治療性內視鏡的核心工具，能夠以精確可控的方式整塊切除黏膜和黏膜下病變。本文將這些器械的臨床應用置於更廣泛的手術流程中，並闡明刀具的設計、材料選擇和使用方式如何影響手術時間、病灶可及性和操作者的舒適度。從技術角度來看，刀具已從簡單的切割刀片發展成為集絕緣、可變刀尖幾何形狀和與電外科能量兼容一體的複雜器械，以控制切割效率和熱效應。

分析2025年美國關稅措施對精密內視鏡儀器的採購、製造決策及購買趨勢的影響。

2025年的關稅環境對跨境採購內視鏡黏膜下剝離刀或其組件的製造商、經銷商和採購部門而言，是一個關鍵的轉捩點。關稅提高了進口商品的到岸成本，促使他們重新評估供應商網路、庫存緩衝和製造地。為此，一些原始設備製造商（OEM）加快了近岸外包和雙重採購策略，以降低關稅風險和運輸波動的影響。同時，其他製造商則尋求設計變更，以在不影響臨床性能的前提下替代課稅組件。這些調整產生了連鎖反應：採購團隊必須權衡短期價格波動與供應商長期永續性之間的關係，而隨著製造商優先考慮本地生產，臨床醫生可能面臨設備配置的頻繁變化。

深度細分分析將產品形態、使用方式、最終用戶環境、臨床應用和材料選擇與採納和採購決策聯繫起來。

細分市場的發展趨勢凸顯了臨床需求、籌資策略和產品設計之間的交集，為製造商和採購機構創造了差異化機會。產品類型的差異——從離合器切割器的扭矩控制到鉤刀的精準定位，再到雙刀的各種切割輪廓以及注重安全性的絕緣刀尖——每一種都針對特定的病變特徵和操作技術，指南臨床實踐中的器械選擇。同樣，一次性使用與可重複使用兩種交付方式也決定了物流、消毒基礎設施和感染控制通訊協定的權衡。一次性使用方式會增加周轉率，而可重複使用的器械則需要檢驗的消毒和維護程序。

區域比較分析突顯了監管細微差別、臨床醫生培訓環境和製造地分佈如何導致全球市場採用率的差異

區域趨勢正在形成差異化的市場，法規結構、臨床醫生培訓和製造地等因素共同影響醫療器材的供應和應用。在美洲，治療性內視鏡領域成熟的臨床經驗、大型醫院系統的集中採購以及對提升手術安全性和效率的創新技術的需求，共同影響市場需求。該地區供應鏈的反應速度和與製造地的接近性也會影響前置作業時間和供應商選擇策略，從而支持國內生產和特定零件的定向進口。

治療性內視鏡領域的差異化因素：以臨床證據、供應鏈韌性與整合服務模式為驅動的公司層面競爭考察

內視鏡黏膜下剝離刀供應商之間的競爭主要圍繞在幾個核心主題：透過臨床證據實現差異化、操作可靠性和綜合支援服務。主要企業致力於迭代式產品研發，旨在改進刀尖幾何形狀和絕緣性能，同時建立臨床夥伴關係，以進行同行評審的研究並制定操作指南。追求一次性產品的企業則專注於供應鏈物流、包裝和一次性使用品質保證。同時，專注於可重複使用平台的企業則投資於耐用材料和檢驗的滅菌通訊協定，以延長產品使用壽命並降低整體擁有成本。

針對製造商、臨床領導者和採購團隊的實用建議：協調產品策略、供應鏈韌性和臨床實施活動

產業領導者應採取協作策略，平衡當前的營運需求與持續的創新投資。首先，應優先考慮供應鏈多元化和近岸外包方案，以降低關稅帶來的成本和前置作業時間波動風險，同時篩選替代材料來源並維持設備性能。其次，應設計滿足不同終端使用者偏好並涵蓋所有產品系列的產品組合，提供諸如離合器切割器和鉤刀等互補型產品，並提供一次性使用和可重複使用兩種型號。第三，需要投資臨床證據的收集和系統的訓練項目。令人信服的療效數據，結合實踐指導，可以加速醫院和專科診所的推廣應用，並促進相關技術納入臨床指南。

研究採用透明的調查方法，結合臨床醫生訪談、監管和專利分析、供應鏈映射和情境測試來檢驗研究結果。

本報告的研究整合了第一手和第二手資料，旨在對內視鏡黏膜下剝離刀的現狀形成全面、可操作的分析。第一手資料包括介入內視鏡醫師、採購經理、消毒技師和臨床負責人的結構化訪談，以及來自手術室和訓練中心的觀察性研究結果。這些定性數據與監管文件、醫療設備使用手冊、臨床試驗報告以及同行評審文獻進行了交叉比對，以檢驗性能聲明和安全性數據。專利研究和材料分析則提供了有關技術差異化和競爭性創新管道的見解。

最後，我們提出一項綜合分析，重點在於闡述設備創新、供應鏈韌性、臨床證據和區域採用趨勢之間的相互作用，以指南策略行動。

總之，內視鏡黏膜下剝離刀正經歷一場變革，其驅動力來自器械幾何結構、材料科學和操作訓練的同步進步。同時，宏觀經濟和政策因素，例如關稅，正在重塑供應鏈策略。隨著越來越多的中心採用先進的切除技術，臨床需求不斷成長，但成功的商業化取決於如何使器械特性適應不同終端使用者、臨床應用和區域法規環境的細微需求。材料和規格的選擇——陶瓷與先進鋼材、一次性使用與可重複使用——仍然是影響滅菌流程、臨床醫生偏好和採購成本的關鍵決策。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 內視鏡黏膜下剝離刀市場（依產品類型分類）

  • 離合器切割器
  • 雙刃刀
  • 鉤刀
  • 絕緣刀尖

9. 內視鏡黏膜下剝離刀市場（依模式分類）

  • 一次性
  • 可重複使用的

第10章 內視鏡黏膜下剝離刀市場（依材料分類）

  • 陶瓷製品
  • 高碳鋼
  • 不銹鋼

第11章 內視鏡黏膜下剝離刀市場（依最終用戶分類）

  • 門診手術中心
  • 醫院
  • 專科診所

第12章 內視鏡黏膜下剝離刀市場（依應用領域分類）

  • 結腸病變
  • 十二指腸病變
  • 食道病變
  • 胃部病變

13. 內視鏡黏膜下剝離刀市場（依地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 內視鏡黏膜下剝離刀市場（按組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

15. 各國內鏡粘膜下剝離刀市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

16. 美國內視鏡黏膜下剝離刀市場

第17章 中國內鏡黏膜下剝離刀市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Boston Scientific Corporation
  • CONMED Corporation
  • Cook Medical LLC
  • Creo Medical
  • ENDO-FLEX GmbH
  • Erbe Elektromedizin GmbH
  • Finemedix
  • FUJIFILM Holdings Corporation
  • Hangzhou AGS
  • Hoya Corporation
  • Kachu
  • KARL STORZ SE & Co. KG
  • Medi-Globe GmbH
  • Medtronic plc
  • Micro-Tech Endoscopy Co., Ltd.
  • MTW Endoskopie Manufaktur
  • Olympus Corporation
  • Ovesco Endoscopy AG
  • STERIS plc
  • Sumitomo Bakelite Co., Ltd.
  • Taewoong Medical Co., Ltd.
  • ZEON CORPORATION
  • Zhejiang Soudon Medical Technology Co., Ltd.
Product Code: MRR-7A380DA7C405

The Endoscopic Submucosal Dissection Knives Market was valued at USD 152.81 million in 2025 and is projected to grow to USD 175.86 million in 2026, with a CAGR of 13.35%, reaching USD 367.47 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 152.81 million
Estimated Year [2026] USD 175.86 million
Forecast Year [2032] USD 367.47 million
CAGR (%) 13.35%

Concise introduction explaining how knife design, procedural demands, clinician needs, and regulatory expectations shape adoption of advanced endoscopic dissection tools

Endoscopic submucosal dissection knives are central to modern gastrointestinal therapeutic endoscopy, enabling en bloc resection of mucosal and submucosal lesions with precision and controlled hemostasis. This introduction frames the clinical purpose of these instruments within the broader procedural pathway, clarifying how knife design, material selection, and mode of use influence procedural time, ease of lesion access, and operator ergonomics. From a technology perspective, knives have evolved from simple cutting edges to complex instruments that integrate insulation, variable tip geometry, and compatibility with electrosurgical energy to manage cutting efficiency and thermal effects.

Adoption dynamics are shaped by a set of interlinked stakeholders: interventional endoscopists demanding high tactile feedback and safety margins, procurement teams balancing single-use infection control concerns with cost-efficiency, and device engineers iterating on materials such as ceramic and advanced steels to optimize durability and cut performance. Regulatory pathways and clinical evidence requirements are becoming more structured, with an emphasis on procedural outcomes and adverse event reporting. Consequently, strategic decisions around product portfolio, training investment, and regional market entry must be grounded in an understanding of procedural workflows and clinician preferences. Throughout this report, the foundational role of knife design in enabling clinician confidence and patient safety is emphasized, with practical implications for commercialization and clinical adoption.

The landscape for endoscopic submucosal dissection knives is undergoing multiple transformative shifts that are redefining product development, procurement, and clinical practice. Technological refinement of tip geometry and insulation is improving precision while reducing collateral thermal injury, and the emergence of specialized designs-such as clutch-style cutters and hooked configurations-has expanded the range of resection techniques clinicians can apply. Parallel to these engineering advances, materials science has introduced alternatives like ceramic and high-carbon steel that deliver distinct trade-offs between edge retention, friction characteristics, and compatibility with energy delivery systems. These material choices now drive product segmentation decisions and influence clinician preference for specific lesion types.

At the same time, the debate between disposable and reusable modes is intensifying as infection control priorities converge with cost and environmental concerns. Disposable devices simplify logistics and reduce cross-contamination risk, whereas reusable instruments demand validated sterilization pathways and durable materials. Training and proctoring programs are also evolving; simulation-based curricula and mentorship networks are accelerating procedural proficiency, which in turn is broadening the set of clinical indications for which ESD is offered. Moreover, procedural settings are diversifying: ambulatory surgical centers, hospitals, and specialty clinics are calibrating their capital and staffing models to accommodate longer therapeutic endoscopy sessions. Finally, macro pressures-such as supply chain localization and tariff changes-are prompting manufacturers to reassess sourcing, inventory strategies, and pricing models, thereby influencing product availability and procurement economics worldwide.

Analysis of how the 2025 United States tariff measures reshaped sourcing, manufacturing decisions, and procurement dynamics for precision endoscopic tools

The tariff environment introduced in 2025 introduced a material inflection point for manufacturers, distributors, and purchasing departments that source endoscopic submucosal dissection knives or their components across borders. Tariffs raise the landed cost of imports and create incentives to re-evaluate supplier networks, inventory buffers, and manufacturing footprints. In response, some original equipment manufacturers accelerated nearshoring and dual-sourcing strategies to mitigate exposure to customs duties and shipping volatility, while others pursued engineering redesigns to substitute tariff-exposed components without compromising clinical performance. These adaptations have ripple effects: procurement teams must weigh short-term price variability against long-term supplier resilience, and clinicians may encounter periodic shifts in device mix as manufacturers prioritize local production.

Concurrently, tariffs interact with reimbursement realities and hospital procurement cycles. Purchasing groups can face tighter negotiation windows and may demand longer performance guarantees or bundled service contracts to offset perceived cost risk. The tariffs also influenced the relative economics of disposable versus reusable devices because import duties applied to consumables can compound per-procedure cost, prompting some centers to favor locally manufactured reusable options when sterilization capacity exists. Importantly, the tariff-driven reconfiguration of supply chains can affect lead times for specialized instruments, potentially altering clinical scheduling and inventory policies. Overall, the cumulative impact is a strategic push toward supply chain agility and a closer alignment between manufacturing location, material selection, and commercial positioning to sustain device availability and clinical continuity.

Deep segmentation insights linking product geometry, usage mode, end-user setting, clinical application, and material choice to adoption and procurement decisions

Segment-specific dynamics reveal where clinical need, procurement strategy, and product engineering intersect to create differentiation opportunities for manufacturers and buying organizations. Product type distinctions-ranging from the torque-control offered by clutch cutters to the targeted access of hook knives, the versatile cutting profiles of dual knives, and the safety-focused insulated tip knives-each map to particular lesion characteristics and operator techniques, informing device selection in real-world practice. Similarly, the mode of delivery, whether disposable or reusable, drives trade-offs in logistics, sterilization infrastructure, and infection control protocols; disposable formats streamline turnover while reusable instruments demand validated sterilization and maintenance pathways.

End-user segmentation matters because procedural volume, staffing models, and capital constraints vary across ambulatory surgical centers, hospitals, and specialty clinics. Ambulatory surgical centers, whether freestanding or hospital-based, prioritize throughput and predictable case scheduling; private and public hospitals differ in procurement governance and budget cycles; and specialty clinics focused on gastrointestinal care or outpatient endoscopy centers tailor investments to subspecialty demand. Clinical application segmentation further refines product fit: device attributes that support en bloc resection and hemostatic control are prioritized for esophageal and gastric lesions, while the handling and reach characteristics required for colonic or duodenal lesions influence the selection between different knife geometries and materials. Material choices-ceramic, high-carbon steel, and stainless steel-also translate into specific user value propositions, such as edge longevity, thermal behavior, and sterilization compatibility. Taken together, these segmentation lenses enable stakeholders to align product portfolios with clinical workflows and procurement realities for maximum impact.

Comparative regional insights showing how regulatory nuance, clinician training ecosystems, and manufacturing footprints drive differential adoption across global markets

Regional dynamics create differentiated markets where regulatory frameworks, clinician training ecosystems, and manufacturing footprints shape device availability and adoption rates. In the Americas, demand is influenced by a combination of established clinical expertise in therapeutic endoscopy, concentrated purchasing through large hospital systems, and an appetite for innovations that enhance procedural safety and throughput. The region's supply chain responsiveness and proximity to manufacturing hubs also affect lead times and supplier selection strategies, supporting both domestic production and targeted importation of specialized components.

Europe, the Middle East & Africa presents a heterogeneous environment where regulatory harmonization across jurisdictions interacts with variable reimbursement policies and diverse clinical capacities. In several markets, centralized procurement and tendering processes create pressure for demonstrable clinical value, whereas in others, private specialty clinics act as early adopters for novel knife designs. Training networks and centers of excellence play an outsized role in clinician adoption in this region, often dictating the pace at which advanced ESD techniques diffuse. Asia-Pacific is characterized by a combination of high procedural volumes in major urban centers, strong local manufacturing capabilities, and rapid clinical adoption driven by procedural expertise and national screening programs. Regional supply chain integration and domestic production capacities often mitigate tariff impacts, while local regulatory pathways and clinician training initiatives accelerate market entry for regionally produced innovations. Across all regions, alignment between clinical evidence, local regulatory expectations, and distribution capabilities is essential to successfully introduce new device variants.

Competitive company-level insights showing how clinical evidence, supply resilience, and integrated service models drive differentiation in therapeutic endoscopy devices

Competitive dynamics among firms supplying endoscopic submucosal dissection knives center on a few persistent themes: differentiation through clinical evidence, operational reliability, and integrated support services. Leading organizations invest in iterative product development that refines tip geometry and insulation, while also establishing clinical partnerships to generate peer-reviewed outcomes and procedural guidance. Companies pursuing disposable formats emphasize supply chain logistics, packaging, and single-use quality assurance, whereas those focusing on reusable platforms invest in durable materials and validated sterilization protocols to extend product lifecycle and reduce total cost of ownership.

Strategic alliances with distributors, hospital purchasing coalitions, and training institutions are common tactics to accelerate clinical adoption and expand installed bases. Additionally, service models that bundle device supply with consumable management, clinician training, and real-world evidence collection offer differentiated value propositions to large end users. Intellectual property around blade design and energy compatibility can create competitive moats, but the faster pace of incremental innovation means firms must balance R&D depth with rapid commercialization. Finally, firms that proactively address supply chain resilience by diversifying components, qualifying alternate manufacturing sites, and developing modular designs are better positioned to navigate tariff volatility and procurement cycles while maintaining clinical continuity for customers.

Actionable recommendations for manufacturers, clinical leaders, and procurement teams to align product strategy, supply resilience, and clinical adoption efforts

Industry leaders should pursue a coordinated strategy that balances immediate operational needs with sustained innovation investments. First, prioritize supply chain diversification and nearshoring options to reduce exposure to tariff-driven cost swings and lead-time variability, while simultaneously qualifying alternate material sources to preserve device performance characteristics. Second, design product portfolios that cover the full procedural spectrum by offering complementary geometries-such as clutch cutters and hook knives-and both disposable and reusable models to meet divergent end-user preferences. Third, invest in clinical evidence generation and structured training programs; compelling outcomes data paired with hands-on proctoring can accelerate adoption in hospitals and specialty clinics and facilitate inclusion in clinical guidelines.

Additionally, engage payers and procurement stakeholders early to demonstrate procedural value and align contracting approaches with institutional budget cycles. Operationally, develop validated sterilization protocols for reusable instruments and consider modular packaging innovations to streamline single-use logistics. From a commercial perspective, build distribution partnerships that offer bundled solutions-device supply, training, and data capture-to reduce friction at the point of adoption. Finally, monitor regulatory and tariff developments closely and use scenario planning to stress-test inventory and pricing strategies. These steps will help manufacturers and health systems deliver consistent clinical outcomes while navigating economic and geopolitical uncertainty.

Transparent research methodology combining clinician interviews, regulatory and patent analysis, supply chain mapping, and scenario testing to validate findings

The research underpinning this report synthesizes primary and secondary evidence to create a robust, actionable view of the endoscopic submucosal dissection knife landscape. Primary inputs included structured interviews with interventional endoscopists, procurement leaders, sterilization engineers, and clinical educators, plus observational insights from procedural sites and training centers. These qualitative inputs were triangulated with a review of regulatory filings, device instructions for use, clinical trial reports, and peer-reviewed literature to validate performance claims and safety profiles. Patent landscaping and materials analysis provided insight into technological differentiation and the competitive innovation pipeline.

Supply chain and tariff impact analysis combined customs data trends, supplier mapping exercises, and manufacturer disclosures to assess sourcing risk and mitigation strategies. Scenario analyses were conducted to evaluate the operational effects of shifts in manufacturing location, tariff imposition, and demand concentration across procedural settings. Throughout, data integrity checks and cross-validation procedures were implemented to ensure consistent interpretation of qualitative and documentary evidence. The methodology emphasizes transparency and reproducibility, leveraging expert validation and iterative review cycles to align findings with clinical practice realities and procurement constraints.

Concluding synthesis emphasizing the interplay between device innovation, supply resilience, clinical evidence, and regional adoption dynamics to guide strategic action

In conclusion, endoscopic submucosal dissection knives are at an inflection point driven by concurrent advances in device geometry, material science, and procedural training, while macroeconomic and policy forces such as tariffs are reshaping supply chain strategy. Clinical demand is broadening as more centers adopt advanced resection techniques, yet successful commercialization depends on aligning device attributes with the nuanced needs of different end users, clinical applications, and regional regulatory environments. Materials and mode choices-whether ceramic versus advanced steels or disposable versus reusable formats-remain pivotal decisions that affect sterilization workflows, clinician preference, and procurement economics.

Going forward, agility in manufacturing and distribution, coupled with strong clinical evidence and structured training initiatives, will determine which technologies achieve widespread adoption. Organizations that proactively address supply resilience, invest in outcomes research, and create practical adoption pathways for clinicians will be best positioned to capture the clinical and commercial benefits of these advanced dissection tools. The net result for patients and providers will be safer, more effective resections and improved procedural confidence across diverse clinical settings.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Endoscopic Submucosal Dissection Knives Market, by Product Type

  • 8.1. Clutch Cutter
  • 8.2. Dual Knife
  • 8.3. Hook Knife
  • 8.4. Insulated Tip Knife

9. Endoscopic Submucosal Dissection Knives Market, by Mode

  • 9.1. Disposable
  • 9.2. Reusable

10. Endoscopic Submucosal Dissection Knives Market, by Material

  • 10.1. Ceramic
  • 10.2. High Carb Steel
  • 10.3. Stainless Steel

11. Endoscopic Submucosal Dissection Knives Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Hospitals
  • 11.3. Specialty Clinics

12. Endoscopic Submucosal Dissection Knives Market, by Application

  • 12.1. Colonic Lesions
  • 12.2. Duodenal Lesions
  • 12.3. Esophageal Lesions
  • 12.4. Gastric Lesions

13. Endoscopic Submucosal Dissection Knives Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Endoscopic Submucosal Dissection Knives Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Endoscopic Submucosal Dissection Knives Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Endoscopic Submucosal Dissection Knives Market

17. China Endoscopic Submucosal Dissection Knives Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Boston Scientific Corporation
  • 18.6. CONMED Corporation
  • 18.7. Cook Medical LLC
  • 18.8. Creo Medical
  • 18.9. ENDO-FLEX GmbH
  • 18.10. Erbe Elektromedizin GmbH
  • 18.11. Finemedix
  • 18.12. FUJIFILM Holdings Corporation
  • 18.13. Hangzhou AGS
  • 18.14. Hoya Corporation
  • 18.15. Kachu
  • 18.16. KARL STORZ SE & Co. KG
  • 18.17. Medi-Globe GmbH
  • 18.18. Medtronic plc
  • 18.19. Micro-Tech Endoscopy Co., Ltd.
  • 18.20. MTW Endoskopie Manufaktur
  • 18.21. Olympus Corporation
  • 18.22. Ovesco Endoscopy AG
  • 18.23. STERIS plc
  • 18.24. Sumitomo Bakelite Co., Ltd.
  • 18.25. Taewoong Medical Co., Ltd.
  • 18.26. ZEON CORPORATION
  • 18.27. Zhejiang Soudon Medical Technology Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY CLUTCH CUTTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY CLUTCH CUTTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY CLUTCH CUTTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY DUAL KNIFE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY DUAL KNIFE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY DUAL KNIFE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY HOOK KNIFE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY HOOK KNIFE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY HOOK KNIFE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY INSULATED TIP KNIFE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY INSULATED TIP KNIFE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY INSULATED TIP KNIFE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY DISPOSABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY DISPOSABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY DISPOSABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY REUSABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY REUSABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY REUSABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY CERAMIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY CERAMIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY CERAMIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY HIGH CARB STEEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY HIGH CARB STEEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY HIGH CARB STEEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY COLONIC LESIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY COLONIC LESIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY COLONIC LESIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY DUODENAL LESIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY DUODENAL LESIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY DUODENAL LESIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY ESOPHAGEAL LESIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY ESOPHAGEAL LESIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY ESOPHAGEAL LESIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY GASTRIC LESIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY GASTRIC LESIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY GASTRIC LESIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 57. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 58. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 59. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 60. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 61. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 62. NORTH AMERICA ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. NORTH AMERICA ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 64. NORTH AMERICA ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 65. NORTH AMERICA ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 66. NORTH AMERICA ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 67. NORTH AMERICA ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 68. LATIN AMERICA ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. LATIN AMERICA ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 70. LATIN AMERICA ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 71. LATIN AMERICA ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 72. LATIN AMERICA ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 73. LATIN AMERICA ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 74. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 75. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 76. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 80. EUROPE ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 86. MIDDLE EAST ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. MIDDLE EAST ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. MIDDLE EAST ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 89. MIDDLE EAST ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 90. MIDDLE EAST ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 91. MIDDLE EAST ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 92. AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 95. AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 96. AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 97. AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. ASEAN ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. ASEAN ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. ASEAN ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 108. ASEAN ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 109. ASEAN ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. ASEAN ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 111. GCC ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GCC ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. GCC ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 114. GCC ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 115. GCC ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. GCC ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPEAN UNION ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPEAN UNION ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPEAN UNION ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPEAN UNION ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPEAN UNION ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPEAN UNION ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 123. BRICS ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. BRICS ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. BRICS ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 126. BRICS ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 127. BRICS ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 128. BRICS ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 129. G7 ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. G7 ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. G7 ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 132. G7 ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 133. G7 ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. G7 ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 135. NATO ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. NATO ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. NATO ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 138. NATO ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 139. NATO ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 140. NATO ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 143. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 145. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 146. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 147. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 148. CHINA ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 149. CHINA ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. CHINA ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 151. CHINA ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 152. CHINA ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 153. CHINA ENDOSCOPIC SUBMUCOSAL DISSECTION KNIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)